Can Blood–Brain Barrier Play a Role in the Development of Cerebral Amyloidosis and Alzheimer's Disease Pathology
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Brain endothelium of intraparenchymal capillaries, small arterioles and venules, and leptomeningeal pial microvessels is the site of the blood–brain barrier (BBB). The BBB has been regarded for almost a century as a ‘‘gate keeper’’ of the neuronal internal milieu. Over the past two decades, it has been recognized that a normal BBB protects neurons from injury not only by rejecting potentially toxic molecules, but also by continuously monitoring and regulating the composition of brain interstitial fluid to adjust optimal conditions for neuronal functioning. The roles of the BBB include, but are not limited to, control of active ion transport, facilitated transport of nutrients (e.g., glucose, amino acids, nucleosides) and vitamins, receptorand/or carrier-mediated transport of peptides and proteins, and specific transfer of certain viruses and leukocytes that may play a crucial role in the development of certain brain pathologies (Zlokovic, 1995). Microvascular lesions have been found in the brains of patients with Alzheimer’s disease (AD) since the classic case described by Alzheimer (O’Brien, 1996). Often, however, vascular mechanisms are neglected and/or considered only coincidental in the pathogenesis of AD. Amyloid b (Ab) peptide, a principal component of cerebrovascular and brain parenchymal amyloid lesions in AD, is central to the pathology of AD because it is neurotoxic—directly by inducing oxidant stress and indirectly by activating microglia (Mattson and Rydel, 1996). It has been shown thatAb also produces vascular endothelial damage (Thomas et al., 1996). Two specific cell-surface acceptor sites that may focus the effects of Ab on target cells have been identified recently: the receptor for advanced glycation end products (RAGE) (Yan et al., 1996) and class A scavenger receptor (SR) (Khoury et al., 1996). However, whether binding of Ab to RAGE and induction of membrane– lipid peroxidation are directly linked or are only associated phenomena has not been clarified (Mattson and Rydel, 1996). Regardless of the fact that the BBB could be a primary target for Ab-induced endothelial cell injury as are neurons and microglia (Thomas et al., 1996; Yan et al., 1996; Khoury et al., 1996), we have shown that specific binding of Ab to brain endothelium can trigger at least one other process. This is receptorand/or carrier-mediated transport of Ab across the BBB that is initiated by peptide binding to the luminal side (Zlokovic et al., 1993). Ab BBB transport does not cause endothelial injury at concentrations of solubleAb up to 400 nM and at over 10 min of exposure, as revealed by the postexposure intactness of the BBB to the impermeable intravascular marker sucrose. It is intriguing that the affinity constant (Km 5 42 nM ) as initially reported for saturable Ab BBB transport in vivo (Zlokovic et al., 1993) is comparable to the vascular endothelial binding affinity constant (Kd 5 40 nM ) determined for Ab binding to brain endothelial RAGE receptor in vitro (Yan et al., 1996). Because the intracellular signal transduction Neurobiology of Disease 4, 23–26 (1997)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils
Khoury, J. E., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., & Loike, J. D. (1996) · Nature · doi:10.1038/382716a0 · Cited by 727 · cited 2×
“Two specific cell-surface acceptor sites that may focus the effects of Ab on target cells have been identified recently: the receptor for advanced glycation end products (RAGE) (Yan et al., 1996) and class A scavenger receptor (SR) (Khoury et al., 1996).”
Backgroundβ-Amyloid-mediated vasoactivity and vascular endothelial damage
Thomas, T., Thomas, G., McLendon, C., Sutton, T., & Mullan, M. (1996) · Nature · doi:10.1038/380168a0 · Cited by 703 · cited 2×
“Regardless of the fact that the BBB could be a primary target for Ab-induced endothelial cell injury as are neurons and microglia (Thomas et al., 1996; Yan et al., 1996; Khoury et al., 1996), we have shown that specific binding of Ab to brain endothelium can trigger at least one other process.”
BackgroundOda, T., Wals, P., Osterburg, H. H., Johnson, S. A., Pasinetti, G. M., Morgan, T. E., Rozovsky, I., Stine, W. B., Snyder, S. W., Holzman, T. F., et al. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1080 · Cited by 352
Ghersi‐Egea, J. ‐., Gorevic, P. D., Ghiso, J., Frangione, B., Patlak, C. S., & Fenstermacher, J. D. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67020880.x · Cited by 222
Cited by
RAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease
Donahue, J. E., Flaherty, S. L., Johanson, C. E., Duncan, J. A., Silverberg, G. D., Miller, M. C., Tavares, R., Yang, W., Wu, Q., Sabo, E., et al. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0115-3 · Cited by 519
Silverberg, G. D., Mayo, M., Saul, T., Rubenstein, E., & McGuire, D. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00487-3 · Cited by 429
Colloidal carriers and blood–brain barrier (BBB) translocation: A way to deliver drugs to the brain?
Garcia-Garcia, E., Andrieux, K., Gil, S., & Couvreur, P. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.031 · Cited by 314
Sigurdsson, E. M., Scholtzova, H., Mehta, P. D., Frangione, B., & Wisniewski, T. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61715-4 · Cited by 258
Mackic, J. B., Stins, M., McComb, J. G., Calero, M., Ghiso, J., Kim, K. S., Yan, S. D., Stern, D., Schmidt, A. M., Frangione, B., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2029 · Cited by 242
“In contrast, the “vascular theory” proposes that A b originates from the circulation, and that circulating sA b could contribute to neurotoxicity if it crosses the brain capillary endothelium, which comprises the blood–brain barrier (BBB) in vivo (14).”
Background
Metadata
- Authors
- Zlokovic, B.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 1997-01
- Volume
- 4
- Issue
- 1
- Pages
- 23-26
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2023602697
- Cited by
- 34
- References
- 4
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Can Blood–Brain Barrier Play a Role in the Development of Cerebral Amyloidosis and Alzheimer's Disease Pathology. https://app.cochat.ai/papers/10.1006/nbdi.1997.0134
- The paper
- Zlokovic, B. (1997). Can Blood–Brain Barrier Play a Role in the Development of Cerebral Amyloidosis and Alzheimer's Disease Pathology. Neurobiology of Disease. https://doi.org/10.1006/nbdi.1997.0134
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.